Antidepressants: Cost Comparison
Antidepressants span SSRIs (sertraline, escitalopram, fluoxetine, citalopram), SNRIs (duloxetine, venlafaxine) and other agents (bupropion, mirtazapine, trazodone). Most are low-cost generics in Medicare Part D.
Across these 9 drugs, average Medicare Part D spending per dosage unit ranges from $0.1178 (Citalopram HBr) to $0.464 (Mirtazapine) for calendar year 2024. Figures are real CMS open data, in US dollars.
How much do antidepressants cost in the US?
As of calendar year 2024, average Medicare Part D spending per dosage unit for these 9 antidepressants ranged from $0.1178 (Citalopram HBr) to $0.464 (Mirtazapine), per CMS open data. These are Medicare program spending figures per billing unit — not pharmacy cash prices, and not medical advice.
| Drug | Generic (active ingredient) | Avg Part D spending / dosage unit | 2024 Part D claims |
|---|---|---|---|
| Trazodone HCl | Trazodone HCl | $0.1467 | 18,424,765 |
| Sertraline HCl | Sertraline HCl | $0.1539 | 16,148,462 |
| Duloxetine HCl | Duloxetine HCl | $0.3506 | 13,094,360 |
| Escitalopram Oxalate | Escitalopram Oxalate | $0.1903 | 12,685,003 |
| Mirtazapine | Mirtazapine | $0.464 | 8,338,476 |
| Fluoxetine HCl | Fluoxetine HCl | $0.1629 | 7,481,805 |
| Bupropion XL | Bupropion HCl | $0.4038 | 6,831,216 |
| Citalopram HBr | Citalopram Hydrobromide | $0.1178 | 6,741,609 |
| Venlafaxine HCl ER | Venlafaxine HCl | $0.3469 | 5,423,191 |
Figures are CMS’s own published Medicare Part D spending values (field Avg_Spnd_Per_Dsg_Unt_Wghtd_2024), reported unchanged. The most-prescribed drug in this group in 2024 was Trazodone HCl (18.4 million claims). View the full dataset on CMS data.cms.gov.
Each drug in detail
Look up any Part D drug
Search the highest-volume Medicare Part D drugs by brand or generic name to see real average spending per dosage unit and 2024 claim volume.
Trazodone HCl
Trazodone HClThis is average Medicare Part D program spending per dosage unit, not a pharmacy cash price or a per-prescription cost. Information only — not medical advice and not a price quote.
Compare other drug classes
Frequently asked questions
- Which antidepressants are compared here?
- This page compares 9 antidepressants from the CMS Medicare Part D dataset (calendar year 2024): Trazodone HCl, Sertraline HCl, Duloxetine HCl, Escitalopram Oxalate, Mirtazapine, Fluoxetine HCl, Bupropion XL, Citalopram HBr, Venlafaxine HCl ER. Each is shown with its real average Medicare Part D spending per dosage unit in US dollars.
- What is the cheapest antidepressant by Medicare spending per unit?
- Among these drugs, Citalopram HBr had the lowest average Medicare Part D spending per dosage unit at $0.1178 (calendar year 2024), and Mirtazapine the highest at $0.464. This is program spending per billing unit, not a retail price, and dosage units differ between drugs.
- Is this the price I would pay for antidepressants?
- No. These figures are average Medicare Part D program spending per dosage unit from CMS open data, not a pharmacy cash price or per-prescription cost. What you pay depends on your pharmacy, insurance, manufacturer, dose and region. This is information only, not medical advice.
- Can a GeraClinic clinician help with depression and anxiety disorders?
- A GeraClinic clinician can review your medication for depression and anxiety disorders, explain the options, and issue or renew a prescription online where clinically appropriate. GeraClinic only lists independently verified, licensed clinicians.
Need help with depression and anxiety disorders?
A GeraClinic clinician can review your medication, explain the options, and issue or renew a prescription online where clinically appropriate — without travelling to a clinic.
Contains public sector information published by U.S. Centers for Medicare & Medicaid Services (CMS) and licensed under the U.S. Government Works / Public Domain. Source: CMS Medicare Part D Spending by Drug (calendar year 2024, published 2026-06-25).
Informational/educational only — not a substitute for professional medical advice; a clinician interprets results.